TrialAntimicrobial agents and chemotherapy2005

Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers.

Sandra Reilley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.